Understanding how bacteria control their infection mechanisms
Delineation of mechanisms underlying response regulator activation in group A Streptococcus
This study is looking at how a specific system in the bacteria that causes strep throat helps it change its behavior in different environments, which could help us understand how it makes people sick.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11018621 on NIH RePORTER |
What this research studies
This research investigates the two-component gene regulatory systems in group A Streptococcus, a significant human pathogen. It focuses on how these systems, particularly the CovRS system, regulate gene expression in response to environmental changes. By analyzing the phosphorylation states of the CovR protein, the research aims to uncover how bacteria modulate their virulence factors, which are crucial for their ability to cause disease. The methodology includes advanced techniques like ChIP-seq and RNA-seq to study gene regulation at a molecular level.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by infections caused by group A Streptococcus.
Not a fit: Patients with infections caused by other types of bacteria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for combating bacterial infections by targeting their regulatory mechanisms.
How similar studies have performed: Previous research has shown success in understanding bacterial regulatory systems, indicating that this approach has potential for meaningful insights.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Shelburne, Samuel a — University of Tx Md Anderson Can Ctr
- Study coordinator: Shelburne, Samuel a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.